Acumapimod
An orally active, potent p38 MAPK inhibitor that potently inhibits ex vivo LPS‐induced TNFα secretion with an IC50 of 44 ng/mL (115 nM) ; inhibits LPS‐stimulated TNFα release in the human whole blood assay with IC50 of 24 nM; shows antiinflammatory activity for treatment of acute as opposed to chronic inflammation disorders.COPD Phase 1 Clinical.
Product Specifications
CAS Number
836683-15-9
Product Name Alternative
BCT-197
Purity
>98% (HPLC)
Solubility
DMSO: 10 mM
Smiles
O=C (NC1CC1) C2=CC=C (C) C (N3N=CC (C (C4=CC=CC (C#N) =C4) =O) =C3N) =C2
Molecular Formula
C22H19N5O2
Molecular Weight
385.4185
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Benzamide, 3-[5-amino-4- (3-cyanobenzoyl) -1H-pyrazol-1-yl]-N-cyclopropyl-4-methyl-
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K6673504 1.0 µg DNA
Bcl11a sgRNA CRISPR Lentivector (Rat) (Target 3)
Sign In for Pricing
View Details LV681181 1.0 µg DNA
MGC105560 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 